APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dual Orexin Receptor Antagonist Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dual Orexin Receptor Antagonist Tablets Industry Growth and Trends Forecast to 2032

27 December 202574 pages

Choose your research edition.

Industry ResearchDual Orexin Receptor Antagonist Tablets Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Dual Orexin Receptor Antagonist Tablets Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Dual Orexin Receptor Antagonist Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dual Orexin Receptor Antagonist Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dual Orexin Receptor Antagonist Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dual Orexin Receptor Antagonist Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dual Orexin Receptor Antagonist Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dual Orexin Receptor Antagonist Tablets include Idorsia, Merck and Eisal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dual Orexin Receptor Antagonist Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dual Orexin Receptor Antagonist Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dual Orexin Receptor Antagonist Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dual Orexin Receptor Antagonist Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dual Orexin Receptor Antagonist Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dual Orexin Receptor Antagonist Tablets Market by Company

Idorsia

Merck

Eisal

Dual Orexin Receptor Antagonist Tablets Segment by Type

5mg per Tablet

25mg per Tablet

20mg per Tablet

15mg per Tablet

10mg per Tablet

Dual Orexin Receptor Antagonist Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Dual Orexin Receptor Antagonist Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dual Orexin Receptor Antagonist Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dual Orexin Receptor Antagonist Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dual Orexin Receptor Antagonist Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dual Orexin Receptor Antagonist Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dual Orexin Receptor Antagonist Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5mg per Tablet Table 2. Major Company of 25mg per Tablet Table 3. Major Company of 20mg per Tablet Table 4. Major Company of 15mg per Tablet Table 5. Major Company of 10mg per Tablet Table 6. Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (K Units) Table 8. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Type (2021-2026) Table 9. Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (US$ Million) Table 10. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Type (2021-2026) Table 11. Global Dual Orexin Receptor Antagonist Tablets Price by Type (2021-2026) & (US$/Unit) Table 12. Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2027-2032) & (K Units) Table 13. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Type (2027-2032) Table 14. Global Dual Orexin Receptor Antagonist Tablets Sales by Type (2027-2032) & (US$ Million) Table 15. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Type (2027-2032) Table 16. Global Dual Orexin Receptor Antagonist Tablets Price by Type (2027-2032) & (US$/Unit) Table 17. North America Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (K Units) Table 18. North America Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (K Units) Table 20. Europe Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (K Units) Table 24. Latin America Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Type (2021-2026) & (US$ Million) Table 27. Dual Orexin Receptor Antagonist Tablets Industry Trends Table 28. Dual Orexin Receptor Antagonist Tablets Industry Drivers Table 29. Dual Orexin Receptor Antagonist Tablets Industry Opportunities and Challenges Table 30. Dual Orexin Receptor Antagonist Tablets Industry Restraints Table 31. Global Dual Orexin Receptor Antagonist Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Dual Orexin Receptor Antagonist Tablets Revenue Market Share by Company (2021-2026) Table 33. Global Dual Orexin Receptor Antagonist Tablets Sales by Company (2021-2026) & (K Units) Table 34. Global Dual Orexin Receptor Antagonist Tablets Sales Share by Company (2021-2026) Table 35. Global Dual Orexin Receptor Antagonist Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Dual Orexin Receptor Antagonist Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Dual Orexin Receptor Antagonist Tablets Major Company Production Sites and Headquarters Table 38. Global Dual Orexin Receptor Antagonist Tablets Company, Product Type & Application Table 39. Global Dual Orexin Receptor Antagonist Tablets Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Dual Orexin Receptor Antagonist Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Dual Orexin Receptor Antagonist Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Region (2021-2026) Table 45. Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2021-2026) & (US$ Million) Table 46. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Region (2021-2026) Table 47. Global Dual Orexin Receptor Antagonist Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2027-2032) & (K Units) Table 49. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Region (2027-2032) Table 50. Global Dual Orexin Receptor Antagonist Tablets Sales by Region (2027-2032) & (US$ Million) Table 51. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Region (2027-2032) Table 52. Global Dual Orexin Receptor Antagonist Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (K Units) Table 55. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Application (2021-2026) Table 56. Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (US$ Million) Table 57. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Application (2021-2026) Table 58. Global Dual Orexin Receptor Antagonist Tablets Price by Application (2021-2026) & (US$/Unit) Table 59. Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2027-2032) & (K Units) Table 60. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Application (2027-2032) Table 61. Global Dual Orexin Receptor Antagonist Tablets Sales by Application (2027-2032) & (US$ Million) Table 62. Global Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Application (2027-2032) Table 63. Global Dual Orexin Receptor Antagonist Tablets Price by Application (2027-2032) & (US$/Unit) Table 64. North America Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (K Units) Table 65. North America Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (K Units) Table 67. Europe Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (K Units) Table 71. Latin America Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Application (2021-2026) & (US$ Million) Table 74. Idorsia Company Information Table 75. Idorsia Business Overview Table 76. Idorsia Dual Orexin Receptor Antagonist Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Idorsia Dual Orexin Receptor Antagonist Tablets Product Portfolio Table 78. Idorsia Recent Development Table 79. Merck Company Information Table 80. Merck Business Overview Table 81. Merck Dual Orexin Receptor Antagonist Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Merck Dual Orexin Receptor Antagonist Tablets Product Portfolio Table 83. Merck Recent Development Table 84. Eisal Company Information Table 85. Eisal Business Overview Table 86. Eisal Dual Orexin Receptor Antagonist Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Eisal Dual Orexin Receptor Antagonist Tablets Product Portfolio Table 88. Eisal Recent Development Table 89. North America Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 90. North America Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 91. North America Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2026) Table 92. North America Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 93. North America Dual Orexin Receptor Antagonist Tablets Sales Market Share Forecast by Country (2027-2032) Table 94. North America Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 95. North America Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026) & (US$ Million) Table 96. North America Dual Orexin Receptor Antagonist Tablets Market Share by Country (2021-2026) Table 97. North America Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 98. North America Dual Orexin Receptor Antagonist Tablets Market Share Forecast by Country (2027-2032) Table 99. Europe Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 100. Europe Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 101. Europe Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2026) Table 102. Europe Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 103. Europe Dual Orexin Receptor Antagonist Tablets Sales Market Share Forecast by Country (2027-2032) Table 104. Europe Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. Europe Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026) & (US$ Million) Table 106. Europe Dual Orexin Receptor Antagonist Tablets Market Share by Country (2021-2026) Table 107. Europe Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. Europe Dual Orexin Receptor Antagonist Tablets Market Share Forecast by Country (2027-2032) Table 109. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 111. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2026) Table 112. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 113. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026) & (US$ Million) Table 116. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Share by Country (2021-2026) Table 117. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Share Forecast by Country (2027-2032) Table 119. Latin America Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Latin America Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 121. Latin America Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2026) Table 122. Latin America Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 123. Latin America Dual Orexin Receptor Antagonist Tablets Sales Market Share Forecast by Country (2027-2032) Table 124. Latin America Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Latin America Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026) & (US$ Million) Table 126. Latin America Dual Orexin Receptor Antagonist Tablets Market Share by Country (2021-2026) Table 127. Latin America Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Latin America Dual Orexin Receptor Antagonist Tablets Market Share Forecast by Country (2027-2032) Table 129. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026) & (K Units) Table 131. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Market Share by Country (2021-2026) Table 132. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 133. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Share by Country (2021-2026) Table 137. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Share Forecast by Country (2027-2032) Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Dual Orexin Receptor Antagonist Tablets Distributors List Table 142. Dual Orexin Receptor Antagonist Tablets Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Dual Orexin Receptor Antagonist Tablets Image Figure 2. Global Dual Orexin Receptor Antagonist Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dual Orexin Receptor Antagonist Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Dual Orexin Receptor Antagonist Tablets Sales (2021-2032) & (K Units) Figure 5. 5mg per Tablet Image Figure 6. Global 5mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 25mg per Tablet Image Figure 8. Global 25mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. 20mg per Tablet Image Figure 10. Global 20mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. 15mg per Tablet Image Figure 12. Global 15mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 13. 10mg per Tablet Image Figure 14. Global 10mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Dual Orexin Receptor Antagonist Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Dual Orexin Receptor Antagonist Tablets Market Share by Type 2025 VS 2032 Figure 17. North America Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Type in 2025 Figure 18. North America Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Type in 2025 Figure 19. Europe Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Europe Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Type in 2025 Figure 23. Latin America Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Dual Orexin Receptor Antagonist Tablets Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital and Clinic Image Figure 30. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Dual Orexin Receptor Antagonist Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Dual Orexin Receptor Antagonist Tablets Market Share by Application 2025 VS 2032 Figure 37. North America Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Application in 2025 Figure 38. North America Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Application in 2025 Figure 39. Europe Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Europe Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Application in 2025 Figure 43. Latin America Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Market Share in Value by Application in 2025 Figure 47. North America Dual Orexin Receptor Antagonist Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Dual Orexin Receptor Antagonist Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Dual Orexin Receptor Antagonist Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Dual Orexin Receptor Antagonist Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Dual Orexin Receptor Antagonist Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Dual Orexin Receptor Antagonist Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Dual Orexin Receptor Antagonist Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Dual Orexin Receptor Antagonist Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Dual Orexin Receptor Antagonist Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Dual Orexin Receptor Antagonist Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Dual Orexin Receptor Antagonist Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Dual Orexin Receptor Antagonist Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Dual Orexin Receptor Antagonist Tablets Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Dual Orexin Receptor Antagonist Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg per Tablet
  • 25mg per Tablet
  • 20mg per Tablet
  • 15mg per Tablet
  • 10mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Idorsia
  • Merck
  • Eisal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dual Orexin Receptor Antagonist Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dual Orexin Receptor Antagonist Tablets Market by Type
  6. 1.3.1 5mg per Tablet
  7. 1.3.2 25mg per Tablet
  8. 1.3.3 20mg per Tablet
  9. 1.3.4 15mg per Tablet
  10. 1.3.5 10mg per Tablet
  11. 1.4 Global Dual Orexin Receptor Antagonist Tablets Market Size by Type
  12. 1.4.1 Global Dual Orexin Receptor Antagonist Tablets Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Dual Orexin Receptor Antagonist Tablets Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Dual Orexin Receptor Antagonist Tablets Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dual Orexin Receptor Antagonist Tablets Industry Trends
  2. 2.2 Dual Orexin Receptor Antagonist Tablets Industry Drivers
  3. 2.3 Dual Orexin Receptor Antagonist Tablets Industry Opportunities and Challenges
  4. 2.4 Dual Orexin Receptor Antagonist Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dual Orexin Receptor Antagonist Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Dual Orexin Receptor Antagonist Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Dual Orexin Receptor Antagonist Tablets Price (2021-2026)
  4. 3.4 Global Dual Orexin Receptor Antagonist Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dual Orexin Receptor Antagonist Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Dual Orexin Receptor Antagonist Tablets Company, Product Type & Application
  7. 3.7 Global Dual Orexin Receptor Antagonist Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dual Orexin Receptor Antagonist Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dual Orexin Receptor Antagonist Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dual Orexin Receptor Antagonist Tablets Tier 1, Tier 2, and Tier 3
4 Dual Orexin Receptor Antagonist Tablets Regional Status and Outlook
  1. 4.1 Global Dual Orexin Receptor Antagonist Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dual Orexin Receptor Antagonist Tablets Historic Market Size by Region
  3. 4.2.1 Global Dual Orexin Receptor Antagonist Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dual Orexin Receptor Antagonist Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dual Orexin Receptor Antagonist Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dual Orexin Receptor Antagonist Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Dual Orexin Receptor Antagonist Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dual Orexin Receptor Antagonist Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dual Orexin Receptor Antagonist Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dual Orexin Receptor Antagonist Tablets by Application
  1. 5.1 Dual Orexin Receptor Antagonist Tablets Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Dual Orexin Receptor Antagonist Tablets Market Size by Application
  6. 5.2.1 Global Dual Orexin Receptor Antagonist Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dual Orexin Receptor Antagonist Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dual Orexin Receptor Antagonist Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Idorsia
  2. 6.1.1 Idorsia Company Information
  3. 6.1.2 Idorsia Business Overview
  4. 6.1.3 Idorsia Dual Orexin Receptor Antagonist Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Idorsia Dual Orexin Receptor Antagonist Tablets Product Portfolio
  6. 6.1.5 Idorsia Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Dual Orexin Receptor Antagonist Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Dual Orexin Receptor Antagonist Tablets Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Eisal
  14. 6.3.1 Eisal Company Information
  15. 6.3.2 Eisal Business Overview
  16. 6.3.3 Eisal Dual Orexin Receptor Antagonist Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eisal Dual Orexin Receptor Antagonist Tablets Product Portfolio
  18. 6.3.5 Eisal Recent Developments
7 North America by Country
  1. 7.1 North America Dual Orexin Receptor Antagonist Tablets Sales by Country
  2. 7.1.1 North America Dual Orexin Receptor Antagonist Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dual Orexin Receptor Antagonist Tablets Market Size by Country
  6. 7.2.1 North America Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dual Orexin Receptor Antagonist Tablets Sales by Country
  2. 8.1.1 Europe Dual Orexin Receptor Antagonist Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dual Orexin Receptor Antagonist Tablets Market Size by Country
  6. 8.2.1 Europe Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dual Orexin Receptor Antagonist Tablets Sales by Country
  2. 10.1.1 South America Dual Orexin Receptor Antagonist Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dual Orexin Receptor Antagonist Tablets Market Size by Country
  6. 10.2.1 South America Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dual Orexin Receptor Antagonist Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dual Orexin Receptor Antagonist Tablets Value Chain Analysis
  2. 12.1.1 Dual Orexin Receptor Antagonist Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dual Orexin Receptor Antagonist Tablets Production Mode & Process
  7. 12.2 Dual Orexin Receptor Antagonist Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dual Orexin Receptor Antagonist Tablets Distributors
  10. 12.2.3 Dual Orexin Receptor Antagonist Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst